Invenomic Capital Management’s Mativ Holdings MATV Stock Holding History

Invenomic Capital Management’s Portfolio MATV Stock Details MATV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2M	Sell	1,348,326 -585,103	-30%	-$5.04M	0.61%	59
2026 Q1	$16.8M	Buy	1,933,429 +214,366	+12%	+$2.46M	0.77%	47
2025 Q4	$20.9M	Buy	1,719,063 +30,182	+2%	+$356K	0.97%	32
2025 Q3	$19.1M	Sell	1,688,881 -431,095	-20%	-$4.27M	0.92%	37
2025 Q2	$14.5M	Sell	2,119,976 -101,621	-5%	-$586K	0.82%	45
2025 Q1	$13.8M	Buy	+2,221,597	New	+$18.1M	0.7%	54
2024 Q2	–	Sell	-482,542	Closed	-$9.05M	–	176
2024 Q1	$9.05M	Sell	482,542 -51,068	-10%	-$762K	0.48%	73
2023 Q4	$8.17M	Buy	533,610 +20,938	+4%	+$283K	0.37%	81
2023 Q3	$7.31M	Buy	512,672 +262,128	+105%	+$4.19M	0.31%	81
2023 Q2	$3.79M	Buy	+250,544	New	+$4.43M	0.19%	95
2023 Q1	–	Sell	-364,104	Closed	-$7.61M	–	163
2022 Q4	$7.61M	Buy	+364,104	New	+$7.89M	0.52%	66
2021 Q4	–	Sell	-36,460	Closed	-$1.26M	–	157
2021 Q3	$1.26M	Buy	36,460 +11,295	+45%	+$422K	0.41%	73
2021 Q2	$1.02M	Buy	+25,165	New	+$1.12M	0.24%	81

Other funds holding MATV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invenomic Capital Management's MATV Position: Q2 2026 in Review

Invenomic Capital Management reduced its Mativ Holdings (MATV) stake by 30% in Q2 2026, selling an estimated $5.04M and leaving 1,348,326 shares worth $10.2M. The position accounts for 0.61% of the portfolio, ranked #59.

Invenomic Capital Management first reported a position in MATV in Q2 2021 and has held it in 13 quarters since. The position peaked at $20.9M in Q4 2025. 207 funds tracked by Wall St. Rank hold MATV as of Q2 2026.

Invenomic Capital Management held 1,348,326 shares of Mativ Holdings worth $10.2M as of Q2 2026.
Invenomic Capital Management sold 585,103 Mativ Holdings shares in Q2 2026, an estimated $5.04M.
Mativ Holdings made up 0.61% of Invenomic Capital Management's portfolio in Q2 2026, its #59 holding.
Invenomic Capital Management first reported a position in Mativ Holdings in Q2 2021 and has held it in 13 quarters since.
Invenomic Capital Management's Mativ Holdings position peaked at $20.9M in Q4 2025.
207 funds tracked by Wall St. Rank held Mativ Holdings as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.